JHJayalekshmi Haripriyan

Jayalekshmi Haripriyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jayalekshmi Haripriyan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phage-mediated biocontrol of Pseudomonas putida and Pseudomonas fluorescens in dairy products using gelatin-based delivery

    by Malavika Binitha Hari, Nimisha Mahesh, S. Neeraja, Nikhil Harikumar, Ambily Vasudevan, Pradeesh Babu, Bipin G. Nair, Geetha B. Kumar, Jayalekshmi Haripriyan

  • Open Access

    Antivirulence Strategy against Candida albicans : Cumin Essential Oil Attenuates Virulence and Enhances Host Immune Defense

    by Nimisha Mahesh, Afia Harith, Anu R. Melge, Attumpurathu Nandini, Aravind Madhavan, Kuniyil Abhinand, Peralam Yegneswaran Prakash, Bipin G. Nair, Geetha B. Kumar, Jayalekshmi Haripriyan

    Candida albicans is a deadly fungal pathogen, particularly in immunocompromised individuals, where a simple superficial infection rapidly transforms into life-threatening systemic candidiasis. Virulence factors of C. albicans include the yeast-to-hyphae transition, biofilm formation, and protease production, which are crucial for establishing infection. Targeting virulence factors is a promising strategy to combat C. albicans infections, which can overcome the limitations of conventional treatment modalities. Essential oils are important in this regard as they are used in traditional medicine due to their antimicrobial capabilities. This study is focused on the antivirulent activity of cumin essential oil (CEO), which significantly reduced the key virulence factors of C. albicans, such as germ tube formation and protease production. A subinhibitory concentration (0.015% v/v) of CEO downregulated the expression of the HWP1, ALS3, and RAS1 genes involved in regulating virulence. In silico studies demonstrated that major compounds of CEO interacted with key amino acid residues of secreted aspartyl proteases (Sap4, Sap5, Sap6) and heat shock protein (Hsp90), a regulator of hyphal formation. CEO significantly reduced biofilm formation of C. albicans in different simulated body fluids such as saliva, artificial urine, and tear fluid. Furthermore, CEO affected the host–pathogen interaction of C. albicans with THP-1 macrophages by increasing phagocytosis and inhibiting germ tube formation. Additionally, CEO treatment modulated the levels of pro-inflammatory and anti-inflammatory cytokines, suggesting that CEO also has immunomodulatory properties, in addition to its antivirulence activity. These results indicate that CEO could be a promising candidate for combating C. albicans infections.


  • Open Access

    A Glycolipid‐Like Biosurfactant Molecule Derived From an Exophiala spinifera Strain With Significant Antibiofilm, Antifungal, and Antiquorum Sensing Activities

    by Amit Yadav, Swathy Sadanandan Anand, Bipin Gopalakrishnan Nair, Jayashree Gopalakrishna Pai, Jayalekshmi Haripriyan, Sudarslal Sadasivan Nair

    A biosurfactant‐producing fungal strain, Exophiala spinifera CSF123, was isolated from cashew oil‐contaminated soil. Internal transcribed spacer sequencing followed by phylogenetic analysis revealed that the isolated fungus shared 98.42% similarity with E. spinifera CBS66.76. The biosurfactant molecule, named ES‐414, produced by the fungus was purified to homogeneity by HPLC, and subsequent electrospray mass spectrometric analysis showed that its neutral mass is 414 Da. The molecule displayed remarkable antibiofilm activity. At concentrations of 15 and 80 μ g/mL, ES‐414 showed 62.17% biofilm inhibition against Candida tropicalis and 66% inhibition against Candida albicans , respectively. It also displayed significant antifungal properties against C. albicans , C. tropicalis , Candida glabrata , Candida parapsilosis , and Candida krusei . ES‐414, in a dose‐dependent manner, inhibited the quorum sensing activity of Chromobacterium violaceum . Thermogravimetric analysis of ES‐414 indicated that the molecule remains stable up to 240°C. Detailed structural characterization using GC‐MS, FTIR, UV‐visible spectroscopy, elemental analysis, Molisch test, TLC analysis, and solubility studies indicated that ES‐414 is a glycolipid‐like molecule.